ACM
TIL icon

ACT Capital Management’s Instil Bio TIL Stock Holding History

ACT Capital Management’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$24K Hold
250
– – 0.03% 65
2022
Q2 		$23K Sell
250
-250
-50% -$35.4K 0.03% 72
2022
Q1 		$108K Hold
500
– – 0.11% 66
2021
Q4 		$171K Hold
500
– – 0.12% 69
2021
Q3 		$179K Hold
500
– – 0.09% 83
2021
Q2 		$194K Buy
+500
New +$185K 0.1% 86

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

ACT Capital Management's TIL Position: Q3 2022 in Review

ACT Capital Management held its Instil Bio (TIL) position steady in Q3 2022 at 250 shares worth $24K. The position accounts for 0.03% of the portfolio, ranked #65.

ACT Capital Management first reported a position in TIL in Q2 2021 and has held it in 6 quarters since. The position peaked at $194K in Q2 2021. 95 funds tracked by Wall St. Rank hold TIL as of Q3 2022.

  • ACT Capital Management held 250 shares of Instil Bio worth $24K as of Q3 2022.
  • ACT Capital Management left its Instil Bio share count unchanged in Q3 2022.
  • Instil Bio made up 0.03% of ACT Capital Management's portfolio in Q3 2022, its #65 holding.
  • ACT Capital Management first reported a position in Instil Bio in Q2 2021 and has held it in 6 quarters since.
  • ACT Capital Management's Instil Bio position peaked at $194K in Q2 2021.
  • 95 funds tracked by Wall St. Rank held Instil Bio as of Q3 2022.

Based on ACT Capital Management's 13F filing for Q3 2022, filed 3 Nov 2022.